Litigation
Apr. 30, 2013
First case over Actos diabetes drug nets $6.5 million for plaintiffs
A Los Angeles jury ordered Asia's largest pharmaceutical company to hand over $6.5 million Friday to a plaintiff and his wife who claimed that the diabetes drug Actos caused his terminal bladder cancer.
Daily Journal Staff Writer
LOS ANGELES - A jury ordered Asia's largest pharmaceutical company to hand over $5 million Friday to a plaintiff who claimed that the diabetes drug Actos caused terminal bladder cancer. The jury awarded the plaintiff's wife an additional $1.5 million.
The case was the first of 3,000 similar complaints filed in state and federal courts around the country to go to trial. Cooper v. Takeda...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In